Cystitis Recurrent
6
4
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
Preventing Recurrent UTI With Vaginal Estrogen
Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis
Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
Bacterial Composition and Recurrent Cystitis in Postmenopausal Women After Treatment With Lactobacilli.